Thermo Fisher Scientific Inc (NYSE: TMO), a globally-focused science company, announced yesterday its financial results for the second quarter ended 29 June 2019.
The company reported revenue for the second quarter of 2019 at USD6.32bn, up 4% compared to the year-ago period.
The firm posted GAAP operating income for the second quarter of 2019 at USD1.50bn, compared with USD0.94bn in the same period in 2018, while second quarter adjusted EPS increased 11% to USD3.04.
Danaher Corporation announces quarterly cash dividend
Abbott announces quarterly common dividend
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva